IL6 and hypertensive disorder: This improvement is likely due to several mechanisms, including reduced cytokines and amyloid precursor proteins (APP). Hypertension (HTN) appears to stimulate the production of cytokines such as IL-6 and other inflammatory mediators from the endothelium. Studies indicate that heightened cytokine levels can initiate an acute phase reaction (APR), damaging endothelial cells.